Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2

BACKGROUND: The receptor binding domain (RBD) of spike protein S1 domain SARS-CoV-2 plays a key role in the interaction with ACE2, which leads to subsequent S2 domain mediated membrane fusion and incorporation of viral RNA into host cells. In this study we tend to repurpose already approved drugs as...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Mol Graph Model
Autori principali: Prajapat, Manisha, Shekhar, Nishant, Sarma, Phulen, Avti, Pramod, Singh, Sanjay, Kaur, Hardeep, Bhattacharyya, Anusuya, Kumar, Subodh, Sharma, Saurabh, Prakash, Ajay, Medhi, Bikash
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Inc. 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7442136/
https://ncbi.nlm.nih.gov/pubmed/32866780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmgm.2020.107716
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi